Skip to content
healthcare.dev

Mucus Relief Extended Release Maximum Strength

NDC 70000-0479, Guaifenesin, tablet, from CARDINAL HEALTH 110, LLC. DBA LEADER 70000.

Product NDC
70000-0479
Status
Listed
Labeler
CARDINAL HEALTH 110, LLC. DBA LEADER 70000
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207342
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70000-0479 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
70000-0479-17000004790114 BLISTER PACK in 1 CARTON (70000-0479-1) / 1 TABLET in 1 BLISTER PACK
70000-0479-27000004790228 BLISTER PACK in 1 CARTON (70000-0479-2) / 1 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 70000-0479 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70000-0479 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70000-0479. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.